Up-regulated microssomal activity measured by the 13C-methacetine breath test is associated with increased fibrogenesis in chronic hepatitis C.

被引：0
|
作者：
Oliveira, AC [1 ]
Parise, ER [1 ]
Lanzoni, V [1 ]
Martins, JR [1 ]
Nader, H [1 ]
Ferraz, ML [1 ]
Reber, M [1 ]
机构：
[1] Univ Fed Sao Paulo, Sao Paulo, Brazil
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1608
引用
收藏
页码：565A / 565A
页数：1
相关论文
共 50 条
  • [31] 13C-methacetin breath test by online molecular correlation spectroscopy compared to APRi and liver biopsy for the assessment of fibrosis in chronic hepatitis C
    Goetze, O.
    Selzner, N.
    Grau, A.
    Fried, M.
    Gerlach, T.
    Muellhaupt, M.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S202 - S202
  • [32] 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C
    Dinesen, L.
    Caspary, W. F.
    Chapman, R. W.
    Dietrich, C. F.
    Sarrazin, C.
    Braden, B.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 (09) : 743 - 748
  • [33] The predictive value of 13C-Methacetin breath test (MBT) for liver transplantation (LT) and death: a seven year follow-up study of 206 chronic hepatitis C patients
    Goetze, Oliver
    Breuer, Monika
    Geier, Andreas
    Fried, Michael
    Weber, Achim
    Ilan, Yaron
    Mullhaupt, Beat
    HEPATOLOGY, 2015, 62 : 231A - 231A
  • [34] [1-13C]-acetate breath test clearly discriminates fatty liver diseases from chronic viral hepatitis
    Sugimoto, M.
    Urita, Y.
    Watanabe, T.
    Maeda, T.
    Sasaki, Y.
    Nakayama, A.
    Nanami, M.
    Ishii, T.
    Hike, K.
    Kato, H.
    Hara, N.
    Honda, Y.
    Watanabe, S.
    Nakanishi, K.
    Shimada, N.
    Miki, K.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S364 - S364
  • [35] The 13C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy
    Park, GJH
    Katelaris, PH
    Jones, DB
    Seow, F
    Lin, BPC
    Le Couteur, DG
    Ngu, MC
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (05) : 395 - 403
  • [36] Histological activity is the main factor associated with liver fibrosis progression in untreated patients with chronic hepatitis C.
    Bastie, A
    Castera, L
    Pawlotsky, J
    Zefrani, E
    Dhumeaux, D
    Roudot-Thoraval, F
    HEPATOLOGY, 1999, 30 (04) : 357A - 357A
  • [37] Hepatitis C virus genotype 1B is associated with more extensive fibrosis but not inflammatory activity in liver biopsies of patients with chronic hepatitis C.
    MeyerWyss, B
    Bianchi, L
    Mantegani, A
    Lavanchy, D
    Dolivo, N
    Gonvers, JJ
    Lauterburg, B
    Meier, R
    Miazza, B
    Renner, EL
    Reichen, J
    Wirth, HP
    Zala, G
    GASTROENTEROLOGY, 1997, 112 (04) : A1333 - A1333
  • [38] 13C-methacetin breath test as quantitative liver function test in patients with chronic hepatitis C:: Continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry
    Goetze, Oliver
    Selzner, Naszia
    Kwiatek, Monika A.
    Fried, Michael
    Gerlach, Tilman
    Muellhaupt, Beat
    GASTROENTEROLOGY, 2006, 130 (04) : A781 - A781
  • [39] The 13C-caffeine breath test distinguishes cirrhosis in chronic hepatitis B infection and is unaffected by short-term lamivudine therapy
    Park, G
    Katelaris, P
    Jones, B
    Seow, F
    Le Couteur, D
    Ngu, M
    GASTROENTEROLOGY, 2004, 126 (04) : A710 - A710
  • [40] THE POINT OF CARE 13C METHACETIN BREATH TEST ACCURATELY ASSESSES INFLAMMATION, FIBROSIS AND PROGNOSIS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C AND NORMAL ALT: A NON INVASIVE LIVER FUNCTION TEST
    Lalazar, Gadi
    Mullhaupt, Beat
    Adar, Tomer
    Goetze, Oliver
    Mizrahi, Meir
    Safadi, Rifaat
    Zigmond, Ehud
    Hemed, Nilla
    Ilan, Yaron
    HEPATOLOGY, 2009, 50 (04) : 1064A - 1065A
12345